Publicaciones en las que colabora con Marta Ferrer Puga (6)

2023

  1. Reliability of a novel electro-medical device for wheal size measurement in allergy skin testing: An exploratory clinical trial

    Allergy: European Journal of Allergy and Clinical Immunology

2019

  1. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1

2017

  1. Improvement of the elevated tryptase criterion to discriminate IgE- from non-IgE-mediated allergic reactions

    Anesthesia and Analgesia, Vol. 127, Núm. 2, pp. 414-419

  2. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Do skin prick test and in vitro techniques diagnose sensitization to peach lipid transfer protein and profilin equally well in allergy to plant food and pollen?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 4, pp. 283-287

2010

  1. Serum total tryptase levels are increased in patients with active chronic urticaria

    Clinical and Experimental Allergy, Vol. 40, Núm. 12, pp. 1760-1766